Comparing Two Methods of Giving Propofol During ERCP with a Special Airway Device

Comparative Study Of Continuous Infusion With Intermittent Bolus Of Propofol During ERCP Using Laryngeal Mask Airway®Gastro™ - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/11/077045

Enrollment

Registered

2024-11-19

Start date

Unknown

Completion date

Unknown

Last updated

2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Continuos infusion of propofol using LMA®Gastro™: infusion of propofol will be started at 9-12 mg/kg/hr. Depth of anaesthesia will be assessed by loss of eyelash reflex/verbal contact.

Eligibility

Inclusion criteria

Inclusion criteria: Patient giving informed and written consent Age 18-60 years American Society of Anaesthesiologists (ASA) physical status I-II[9] Patient posted for elective ERCP

Exclusion criteria

Exclusion criteria: Edentulous patient Mallampati class IV or any Facial deformity H/O Obstructive sleep apnea Allergy to propofol ,lipid emulsion or egg lecithin High risk of aspiration i.e. Gatroesophageal reflux disease Pregnant patients

Design outcomes

Primary

Measure	Time frame
To compare recovery time in both the groups. To compare the ease of LMA®Gastro™ insertion in both the groups. Timepoint: To compare recovery time in both the groups at 1min,2min,3min,5min,10min,15min,20min,25min and every 5 min afterwards. To compare the ease of LMA®Gastro™ insertion in both the group at Jaw relaxation of patient, Gagging cough reflex and Patient Movement	—

Secondary

Measure	Time frame
To note time to achieve induction and total dose of propofol required in both the groups. To evaluate the ease of insertion and success rate of endoscope device through the endoscopic channel provided in LMA®Gastro™ in both the groups. Time to post anaesthesia care unit discharge between the two groups. Hemodynamic Parameters in both the groupsTimepoint: Propofol used in induction in mg (Dose-Propofol-1.5mg to 2.5mg/kg). total dose of propofol will be lowered to 2-5mg/kg/hr then titrated to 1-2mg/kg/hr. time to insert endoscope via Lma gastro will be noted in seconds. time taken for PACU discharge will be noted in both groups in minutes 0,5,10,15,20,25,30 Hemodynamic vital parameters will be noted in both the groups 0min,15min,30min,45min,60min,75min,90mins	—

Measure

Time frame

To note time to achieve induction and total dose of propofol required in both the groups. To evaluate the ease of insertion and success rate of endoscope device through the endoscopic channel provided in LMA®Gastro™ in both the groups. Time to post anaesthesia care unit discharge between the two groups. Hemodynamic Parameters in both the groupsTimepoint: Propofol used in induction in mg (Dose-Propofol-1.5mg to 2.5mg/kg). total dose of propofol will be lowered to 2-5mg/kg/hr then titrated to 1-2mg/kg/hr. time to insert endoscope via Lma gastro will be noted in seconds. time taken for PACU discharge will be noted in both groups in minutes 0,5,10,15,20,25,30 Hemodynamic vital parameters will be noted in both the groups 0min,15min,30min,45min,60min,75min,90mins

—

Countries

India

Contacts

Public ContactDr Md Shahbaz Alam

TMU MEDICAL COLLEGE AND HOSPITAL MORADABAD

pallaviahluwalia22@gmail.com8218628850

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026